Free Trial

MarketBeat Instant News Alerts

Domino's Pizza Group logo with Consumer Cyclical background

Domino's Pizza Group plc (LON:DOM) Insider Purchases £80,151.50 in Stock

MarketBeat

Domino's Pizza Group plc (LON:DOM - Get Free Report) insider Mitesh Patel acquired 38,350 shares of the stock in a transaction dated Friday, August 8th. The shares were bought at an average cost of GBX 209 ($2.81) per share, for a total transaction of £80,151.50 ($107,759.48).

LON:DOM
Read Domino's Pizza Group plc (LON:DOM) Insider Purchases £80,151.50 in Stock
Pagaya Technologies logo with Finance background

Canaccord Genuity Group Issues Positive Forecast for Pagaya Technologies (NASDAQ:PGY) Stock Price

MarketBeat

Canaccord Genuity Group lifted their price target on shares of Pagaya Technologies from $28.00 to $36.00 and gave the company a "buy" rating in a research report on Monday.

NASDAQ:PGY
Read Canaccord Genuity Group Issues Positive Forecast for Pagaya Technologies (NASDAQ:PGY) Stock Price
Penguin Solutions logo with Computer and Technology background

Penguin Solutions (NASDAQ:PENG) Given Buy Rating at Rosenblatt Securities

MarketBeat

Rosenblatt Securities restated a "buy" rating and issued a $27.00 price objective on shares of Penguin Solutions in a research note on Monday.

NASDAQ:PENG
Read Penguin Solutions (NASDAQ:PENG) Given Buy Rating at Rosenblatt Securities
Nexstar Media Group logo with Consumer Discretionary background

Barrington Research Issues Positive Forecast for Nexstar Media Group (NASDAQ:NXST) Stock Price

MarketBeat

Barrington Research boosted their price objective on shares of Nexstar Media Group from $200.00 to $225.00 and gave the stock an "outperform" rating in a report on Monday.

NASDAQ:NXST
Read Barrington Research Issues Positive Forecast for Nexstar Media Group (NASDAQ:NXST) Stock Price
Intellia Therapeutics logo with Medical background

Chardan Capital Issues Pessimistic Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

MarketBeat

Chardan Capital decreased their price objective on Intellia Therapeutics from $68.00 to $60.00 and set a "buy" rating on the stock in a research note on Monday.

NASDAQ:NTLA
Read Chardan Capital Issues Pessimistic Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price
Niagen Bioscience logo with Medical background

Niagen Bioscience (NASDAQ:NAGE) Given New $12.00 Price Target at HC Wainwright

MarketBeat

HC Wainwright increased their price objective on shares of Niagen Bioscience from $11.00 to $12.00 and gave the stock a "buy" rating in a report on Monday.

NASDAQ:NAGE
Read Niagen Bioscience (NASDAQ:NAGE) Given New $12.00 Price Target at HC Wainwright

Trending News

All MarketBeat Instant News Alerts

MaxCyte logo with Medical background

MaxCyte's (MXCT) "Neutral" Rating Reiterated at BTIG Research

MarketBeat
NASDAQ:MXCT
Read MaxCyte's (MXCT) "Neutral" Rating Reiterated at BTIG Research
Microvision logo with Computer and Technology background

Microvision (NASDAQ:MVIS) Earns Buy Rating from D. Boral Capital

MarketBeat
NASDAQ:MVIS
Read Microvision (NASDAQ:MVIS) Earns Buy Rating from D. Boral Capital
MarketAxess logo with Finance background

Jefferies Financial Group Cuts MarketAxess (NASDAQ:MKTX) Price Target to $208.00

MarketBeat
NASDAQ:MKTX
Read Jefferies Financial Group Cuts MarketAxess (NASDAQ:MKTX) Price Target to $208.00
Mirum Pharmaceuticals logo with Medical background

Mirum Pharmaceuticals (NASDAQ:MIRM) PT Set at $89.00 by Stifel Nicolaus

MarketBeat
NASDAQ:MIRM
Read Mirum Pharmaceuticals (NASDAQ:MIRM) PT Set at $89.00 by Stifel Nicolaus
Lyft logo with Computer and Technology background

Lyft's (LYFT) "Neutral" Rating Reiterated at Susquehanna

MarketBeat
NASDAQ:LYFT
Read Lyft's (LYFT) "Neutral" Rating Reiterated at Susquehanna
Lineage logo with Finance background

Lineage (NASDAQ:LINE) Receives "Underperform" Rating from Bank of America

MarketBeat
NASDAQ:LINE
Read Lineage (NASDAQ:LINE) Receives "Underperform" Rating from Bank of America
Innoviva logo with Medical background

HC Wainwright Forecasts Strong Price Appreciation for Innoviva (NASDAQ:INVA) Stock

MarketBeat
NASDAQ:INVA
Read HC Wainwright Forecasts Strong Price Appreciation for Innoviva (NASDAQ:INVA) Stock
Innoviva logo with Medical background

Innoviva (NASDAQ:INVA) Coverage Initiated by Analysts at Oppenheimer

MarketBeat
NASDAQ:INVA
Read Innoviva (NASDAQ:INVA) Coverage Initiated by Analysts at Oppenheimer
i3 Verticals logo with Computer and Technology background

Stephens Reaffirms "Overweight" Rating for i3 Verticals (NASDAQ:IIIV)

MarketBeat
NASDAQ:IIIV
Read Stephens Reaffirms "Overweight" Rating for i3 Verticals (NASDAQ:IIIV)
ICF International logo with Business Services background

ICF International (NASDAQ:ICFI) Price Target Raised to $107.00

MarketBeat
NASDAQ:ICFI
Read ICF International (NASDAQ:ICFI) Price Target Raised to $107.00
Hut 8 logo with Finance background

Hut 8 (NASDAQ:HUT) Price Target Lowered to $23.00 at Rosenblatt Securities

MarketBeat
NASDAQ:HUT
Read Hut 8 (NASDAQ:HUT) Price Target Lowered to $23.00 at Rosenblatt Securities
Fidus Investment logo with Finance background

Fidus Investment (NASDAQ:FDUS) Price Target Raised to $21.50

MarketBeat
NASDAQ:FDUS
Read Fidus Investment (NASDAQ:FDUS) Price Target Raised to $21.50
Expedia Group logo with Retail/Wholesale background

Susquehanna Reaffirms Neutral Rating for Expedia Group (NASDAQ:EXPE)

MarketBeat
NASDAQ:EXPE
Read Susquehanna Reaffirms Neutral Rating for Expedia Group (NASDAQ:EXPE)
Doximity logo with Medical background

Doximity (NASDAQ:DOCS) Price Target Raised to $69.00 at Piper Sandler

MarketBeat
NASDAQ:DOCS
Read Doximity (NASDAQ:DOCS) Price Target Raised to $69.00 at Piper Sandler
DoorDash logo with Computer and Technology background

Jefferies Financial Group Raises DoorDash (NASDAQ:DASH) Price Target to $265.00

MarketBeat
NASDAQ:DASH
Read Jefferies Financial Group Raises DoorDash (NASDAQ:DASH) Price Target to $265.00
DoorDash logo with Computer and Technology background

DoorDash's (DASH) Positive Rating Reaffirmed at Susquehanna

MarketBeat
NASDAQ:DASH
Read DoorDash's (DASH) Positive Rating Reaffirmed at Susquehanna
CervoMed logo with Medical background

CervoMed (NASDAQ:CRVO) Price Target Raised to $15.00

MarketBeat
NASDAQ:CRVO
Read CervoMed (NASDAQ:CRVO) Price Target Raised to $15.00
CervoMed logo with Medical background

Chardan Capital Reaffirms "Buy" Rating for CervoMed (NASDAQ:CRVO)

MarketBeat
NASDAQ:CRVO
Read Chardan Capital Reaffirms "Buy" Rating for CervoMed (NASDAQ:CRVO)
Crinetics Pharmaceuticals logo with Medical background

JMP Securities Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $86.00

MarketBeat
NASDAQ:CRNX
Read JMP Securities Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $86.00
Core Scientific logo with Finance background

HC Wainwright Reaffirms Neutral Rating for Core Scientific (NASDAQ:CORZ)

MarketBeat
NASDAQ:CORZ
Read HC Wainwright Reaffirms Neutral Rating for Core Scientific (NASDAQ:CORZ)
Collegium Pharmaceutical logo with Medical background

Collegium Pharmaceutical's (COLL) Buy Rating Reiterated at HC Wainwright

MarketBeat
NASDAQ:COLL
Read Collegium Pharmaceutical's (COLL) Buy Rating Reiterated at HC Wainwright
Climb Global Solutions logo with Business Services background

Barrington Research Reaffirms "Outperform" Rating for Climb Global Solutions (NASDAQ:CLMB)

MarketBeat
NASDAQ:CLMB
Read Barrington Research Reaffirms "Outperform" Rating for Climb Global Solutions (NASDAQ:CLMB)
Chime Financial logo with Financial Services background

Canaccord Genuity Group Reaffirms "Buy" Rating for Chime Financial (NASDAQ:CHYM)

MarketBeat
NASDAQ:CHYM
Read Canaccord Genuity Group Reaffirms "Buy" Rating for Chime Financial (NASDAQ:CHYM)
Crescent Biopharma logo with Medical background

HC Wainwright Begins Coverage on Crescent Biopharma (NASDAQ:CBIO)

MarketBeat
NASDAQ:CBIO
Read HC Wainwright Begins Coverage on Crescent Biopharma (NASDAQ:CBIO)

Featured Articles and Offers

Sector News